Case Discussion: DMD

The France Foundation

C. Proud, A. Veerapandiyan, C. Mcdonald

DMD Management in the Era of Gene Therapy

The France Foundation

A. Veerapandiyan, C. Zaidman

Duchenne Muscular Dystrophy and Gene Therapy: What's On the Horizon?

The France Foundation

H. Abdel-Hamid, A. Veerapandiyan

Impact of Combination Therapies and Exercise Programs for Neuromuscu…

The France Foundation

A. Veerapandiyan, J. Brandsema, L. Servais

Emerging Therapies for Neuromuscular Diseases in 2021: ALS, Dystroph…

Houston Methodist

E. Greene

Approach to a Child with Delayed Walking

UCSF School of Medicine

Y. Mitsuya

The Technology Will See You Now: Digital Endpoints and AI Applicatio…

Henry J. Kaminski

Principles of AAV Gene Therapy for Inherited Neurological Disorders:…

American Neurological Association

S. G. Kaler, B. Traynor

Newborn Screening for Duchenne Muscular Dystrophy

United Scientific Group

R. Rodney Howell

Cell-Based Therapies for Neuromuscular Diseases

Houston Methodist

B. Liao

Improving the Management of Patients With DMD: Emerging Evidence and…

The France Foundation

C. Proud, E. Finanger

Clinical Updates in DMD

The France Foundation

J. Brandsema, A. Veerapandiyan, L. Servais

Introduction to Dystrophin

The France Foundation

C. Mcdonald

Pediatric Neuromuscular Disorders

ZINCARE

J. Wilmshurst

Heterogeneity in Muscular Dystrophies

The France Foundation

L. Servais, J. Brandsema

Gene Therapies for DMD

The France Foundation

C. Proud, A. Veerapandiyan

Registries and Natural History Studies in DMD

The France Foundation

L. Servais, J. Brandsema

AAV Vector Shedding

The France Foundation

J. Brandsema

A New Therapy for Duchenne

University of Utah Neurology

C. Espinoza

Neuromuscular Cases: Lessons From Fellowship

University of Miami

A. Shahein